Literature DB >> 26133772

PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway.

Jinye Xu1, Junbo Cai2, Xiaoyan Jin2, Jingjin Yang3, Qinyan Shen1, Xiaofei Ding3, Yong Liang1.   

Abstract

The p53-inducible gene 3 (PIG3 or TP53I3) is a downstream gene of p53, which can be involved in the process of apoptosis induced by p53 via the production of reactive oxygen species (ROS). However, the functional significance of PIG3 in cancer remains to be determined. This aim of this study was to examine the mRNA and protein expression of PIG3 in papillary thyroid carcinoma (PTC) and normal thyroid tissues, assess the relationship between PIG3 expression and clinicopathological parameters in PTC and examine its role in the proliferation of PTC cell lines. The results showed that PIG3 was aberrantly overexpressed in the majority of specimens of PTC while the expression of p53 was lower in PTC compared with normal thyroid tissues. Anti-PIG3 immuno-reactivity positively correlated with TNM grade. In the PTC cell lines, PIG3 silencing using small interfering RNA (siRNAs) impaired their ability of proliferation and decreased the activity of the PI3K/AKT/PTEN pathway. The results suggested that PIG3 plays an oncogenic role in PTC via the regulation of the PI3K/AKT/PTEN pathway and support the exploration of PIG3 as a novel biomarker for patients with PTC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26133772     DOI: 10.3892/or.2015.4096

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer.

Authors:  Wei-Zhong Sheng; Yu-Sheng Chen; Chuan-Tao Tu; Juan He; Bo Zhang; Wei-Dong Gao
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Clinical characteristics and molecular pathology of skull ectopic thyroid cancer.

Authors:  Longxing Cao; Zhongyong Wang; Jiawei Ma; Jinsheng Chen; Haojiang Zhu; Xiaohua Zhou; Qing Zhu; Jun Dong; Qing Lan; Qiang Huang
Journal:  Ann Transl Med       Date:  2016-12

3.  PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients.

Authors:  Ming Li; Shanhu Li; Biao Liu; Meng-Meng Gu; Shitao Zou; Bei-Bei Xiao; Lan Yu; Wei-Qun Ding; Ping-Kun Zhou; Jundong Zhou; Zeng-Fu Shang
Journal:  J Exp Clin Cancer Res       Date:  2017-03-04

4.  The oncogenic effects of p53-inducible gene 3 (PIG3) in colon cancer cells.

Authors:  Seon-Joo Park; Hong Beum Kim; Jeeho Kim; Sanggon Park; Seok Won Kim; Jung-Hee Lee
Journal:  Korean J Physiol Pharmacol       Date:  2017-02-21       Impact factor: 2.016

Review 5.  p53 and metabolism: from mechanism to therapeutics.

Authors:  Fernando M Simabuco; Mirian G Morale; Isadora C B Pavan; Ana P Morelli; Fernando R Silva; Rodrigo E Tamura
Journal:  Oncotarget       Date:  2018-05-04

6.  miR-218 overexpression suppresses tumorigenesis of papillary thyroid cancer via inactivation of PTEN/PI3K/AKT pathway by targeting Runx2.

Authors:  Mingkun Han; Liwei Chen; Yang Wang
Journal:  Onco Targets Ther       Date:  2018-09-28       Impact factor: 4.147

7.  Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway.

Authors:  Chao Liu; Zhiping Feng; Ting Chen; Juan Lv; Pengjie Liu; Li Jia; Jialun Zhu; Fukun Chen; Chuanzhou Yang; Zhiyong Deng
Journal:  Cell Cycle       Date:  2018-12-30       Impact factor: 5.173

8.  Microarray analyses reveal genes related to progression and prognosis of esophageal squamous cell carcinoma.

Authors:  Mao Qixing; Dong Gaochao; Xia Wenjie; Wang Anpeng; Chen Bing; Ma Weidong; Xu Lin; Jiang Feng
Journal:  Oncotarget       Date:  2017-08-12

9.  p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.

Authors:  Meng-Meng Gu; Dexuan Gao; Ping-An Yao; Lan Yu; Xiao-Dong Yang; Chun-Gen Xing; Jundong Zhou; Zeng-Fu Shang; Ming Li
Journal:  Cancer Sci       Date:  2018-10-26       Impact factor: 6.716

Review 10.  Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.

Authors:  Ningni Jiang; Qijie Dai; Xiaorui Su; Jianjiang Fu; Xuancheng Feng; Juan Peng
Journal:  Mol Biol Rep       Date:  2020-04-24       Impact factor: 2.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.